1 completed, 1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Anthra Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer BCG vaccine, valrubicin, conventional surgery - Bladder Cancer | Phase 2 | Completed | Anthra Pharmaceuticals | 1998-11-01 | 2013-01-31 | |
| Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer valrubicin, conventional surgery - Bladder Cancer | Phase 3 | Unknown | Anthra Pharmaceuticals | 300 | 1996-12-01 | 2013-11-06 |
valrubicin (2) · BCG Vaccine (1)
United States (2) · Canada (1)
Colin P. Dinney, MD (1) · Peter R. Carroll, MD (1)